What is the current valuation of the vaccine technologies market in Germany as of 2024?

The market valuation was $2509.65 Million in 2024. Read More

What is the projected market valuation for Germany's vaccine technologies by 2035?

The projected valuation for 2035 is $7756.0 Million. Read More

What is the expected CAGR for the vaccine technologies market in Germany during the forecast period 2025 - 2035?

The expected CAGR during this period is 10.8%. Read More

Which companies are the key players in the Germany vaccine technologies market?

Key players include Pfizer, Moderna, AstraZeneca, Johnson & Johnson, Sanofi, GSK, Novavax, Merck, and Bharat Biotech. Read More

How does the market for parenteral vaccines compare to oral vaccines in Germany?

The parenteral segment was valued at $1500.0 Million in 2024, while the oral segment was valued at $1009.65 Million. Read More

What are the primary disease indications for vaccines in Germany?

The primary disease indications are for Viral Diseases and Bacterial Diseases, valued at $1500.0 Million and $1009.65 Million, respectively. Read More

What age groups are targeted by vaccine technologies in Germany?

The market targets Pediatric and Adult age groups, with valuations of $600.0 Million and $1909.65 Million, respectively. Read More

What distribution channels are utilized for vaccines in Germany?

Distribution channels include Hospital & Retail Pharmacies, Government Suppliers, and Others, with respective valuations of $1000.0 Million, $800.0 Million, and $709.65 Million. Read More

What trends are expected to shape the vaccine technologies market in Germany by 2035?

Trends may include advancements in vaccine types, increased focus on specific disease indications, and growth in distribution channels. Read More

Germany Vaccine Technologies Market

Q: What are the main types of vaccine technologies available in Germany?

The main types include Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, and Toxoid. Read More

ID: MRFR/Pharma/50284-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

Germany Vaccine Technologies Market Research Report: Size, Share, Trend Analysis By Types (Recombinant, Conjugate, Subunit, Inactivated, Live Attenuated, Toxoid), By Route of Administration (Parenteral, Oral), By Disease Indication (Viral Diseases, Bacterial Diseases), By Age Group (Pediatric, Adults) and By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Germany Vaccine Technologies Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.8%

2024 Market Size$ 2,509.65 Million

2025 Market Size$ 2,780.69 Million

2035 Market Size$ 7,756 Million

Key Players

Pfizer

Moderna

AstraZeneca

Johnson & Johnson

Sanofi

GSK

Trends

Emergence of mRNA Technologies
Increased Public-Private Partnerships
Focus on Personalized Vaccination Strategies

Opportunities

Rising Demand for Vaccination
Emerging Infectious Disease Threats
Government Support and Funding Initiatives

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Recombinant/Conjugate/Subunit
  2. 4.1.2 Inactivated
  3. 4.1.3 Live Attenuated
  4. 4.1.4 Toxoid
2. 4.2 Medical Device, BY Route of Administration (USD Million)
  1. 4.2.1 Parenteral
  2. 4.2.2 Oral
3. 4.3 Medical Device, BY Disease Indication (USD Million)
  1. 4.3.1 Viral Diseases
  2. 4.3.2 Bacterial Diseases
4. 4.4 Medical Device, BY Age Group (USD Million)
  1. 4.4.1 Pediatric
  2. 4.4.2 Adults
5. 4.5 Medical Device, BY Distribution Channel (USD Million)
  1. 4.5.1 Hospital & Retail Pharmacies
  2. 4.5.2 Government Suppliers
  3. 4.5.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Pfizer (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Moderna (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 AstraZeneca (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sanofi (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 GSK (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Novavax (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bharat Biotech (IN)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GERMANY MARKET ANALYSIS BY TYPE
3. 6.3 GERMANY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
4. 6.4 GERMANY MARKET ANALYSIS BY DISEASE INDICATION
5. 6.5 GERMANY MARKET ANALYSIS BY AGE GROUP
6. 6.6 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. 6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF MEDICAL DEVICE
10. 6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
12. 6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
14. 6.14 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 MEDICAL DEVICE, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
16. 6.16 MEDICAL DEVICE, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
17. 6.17 MEDICAL DEVICE, BY DISEASE INDICATION, 2024 (% SHARE)
18. 6.18 MEDICAL DEVICE, BY DISEASE INDICATION, 2024 TO 2035 (USD Million)
19. 6.19 MEDICAL DEVICE, BY AGE GROUP, 2024 (% SHARE)
20. 6.20 MEDICAL DEVICE, BY AGE GROUP, 2024 TO 2035 (USD Million)
21. 6.21 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. 6.22 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  3. 7.2.3 BY DISEASE INDICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Million)
  5. 7.2.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Germany Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

Recombinant/Conjugate/Subunit
Inactivated
Live Attenuated
Toxoid

Medical Device By Route of Administration (USD Million, 2025-2035)

Parenteral
Oral

Medical Device By Disease Indication (USD Million, 2025-2035)

Viral Diseases
Bacterial Diseases

Medical Device By Age Group (USD Million, 2025-2035)

Pediatric
Adults

Medical Device By Distribution Channel (USD Million, 2025-2035)

Hospital & Retail Pharmacies
Government Suppliers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”